Revolution Medicines, Inc. is 6.8x more valuable than CRISPR Therapeutics AG by market capitalization ($32.71 B vs $4.80 B). Every figure below comes from audited SEC filings and refreshed market data.
| Metric | CRSP | RVMD |
|---|---|---|
| Market cap | $4.80 B | $32.71 B |
| US-listed rank | #1436 | #439 |
| Revenue (latest FY) | $3.51M | $0.00 |
| Net income (latest FY) | -$581.60M | -$1.13B |
| Net margin | -16569.8% | - |
| SEC filings | 837 | 782 |
Revolution Medicines, Inc. is 6.8x more valuable than CRISPR Therapeutics AG by market capitalization ($32.71 B vs $4.80 B).
In their latest fiscal years, CRISPR Therapeutics AG reported $3.51M in revenue while Revolution Medicines, Inc. reported $0.00.
Full pages: CRISPR Therapeutics AG and Revolution Medicines, Inc., or browse the full rankings.